The role of neuronal nitric oxide synthase in the development of bone cancer pain

张娟,马正良,周晓芳,高勤,王俊华,夏小萍
DOI: https://doi.org/10.3760/cma.j.issn.1673-4378.2008.06.007
2008-01-01
Abstract:Objective To explore the role of neuronal nitric oxide synthase (nNOS) in the development of bone pain cancer of mice. Methods 72 C31-1/Hej mice were divided randomly into tumor group ( n =40) and sham group ( n = 32). Tumor group was divided randomly into T7, T10, T14, L (L-NMMA) and C group (vehicle). The Sham group mice were further divided randomly into $7 group, S10 group, S14 group and S group (vehicle). Osteosarcoma NCTC 2472 cells were implanted into the intramedullary space of the right femurs of mice to induce ongoing bone cancerrelated pain behaviors. The sham group was inoculated by α-MEM without any cells. Mice were killed according to the corresponding time. Reverse transcriptive polymerase chain reaction (RT-PCR) was applied to analysis the expression of nNOS mRNA. The mice were observed the changes of pain behaviors in L Group, such as paw withdrawal mechanical threshold (PWMT) and paw withdrawal thermal latency ( PWTL), at 2 h, 12 h and 24 h after intrathecal administration of 50 p.g L-NMMA. Results The levels of nNos mRua in spinal cord of tumor mice were increased ( P < 0.05 ) at 10 d after incucation and decreased at 14 d. The pain behaviors were attenuated by intrathecal administration of μg L-NMMA. Conclusion nNOS in spinal cord may participate in the development of bone cancer pain in the early time, and the maintenance of bone cancer pain may depend on the other type of NOS.
What problem does this paper attempt to address?